Funding for this research was provided by:
Cancer, Cardiovascular, and Pulmonary Disease Program
Received: 7 July 2021
Accepted: 28 September 2022
First Online: 18 October 2022
: This program was reviewed and designated as exempt by the Colorado Multiple Institutional Review Board [CitationRef removed]. Informed consent was obtained from all program participants who were interviewed and whose information was used in the evaluation. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors have no competing interests.